| Issue Date | Title | Author(s) |
| 2019-03-04 | High expression of IDO1 and TGF-?1 during recurrence and post infection clearance with Chlamydia trachomatis, are independent of host IFN-? response | Ziklo, N; Huston, WM; Taing, K; Timms, P |
| 2013-11-15 | The IL-6 response to Chlamydia from primary reproductive epithelial cells is highly variable and may be involved in differential susceptibility to the immunopathological consequences of chlamydial infection | Cunningham, K; Stansfield, SH; Patel, P; Menon, S; Kienzle, V; Allan, JA; Huston, WM |
| 2017-06-14 | Safety and immunogenicity of a prototype anti-Chlamydia pecorum recombinant protein vaccine in lambs and pregnant ewes | Desclozeaux, M; Jelocnik, M; Whitting, K; Saifzadeh, S; Bommana, S; Potter, A; Gerdts, V; Timms, P; Polkinghorne, A |
| 2005-01-01 | Androgen receptor gene expression in leucocytes is hormonally regulated: Implications for gender differences in disease pathogenesis | Sader, MA; McGrath, KCY; Hill, MD; Bradstock, KF; Jimenez, M; Handelsman, DJ; Celermajer, DS; Death, AK |
| 2017-01-03 | Systemic immunization with rPotD reduces Streptococcus pneumoniae nasopharyngeal colonization in mice | Converso, TR; Goulart, C; Rodriguez, D; Darrieux, M; Leite, LCC |
| 2018-02-01 | CXCL10, CXCL11, HLA-A and IL-1β are induced in peripheral blood mononuclear cells from women with Chlamydia trachomatis related infertility | Menon, S; Alexander, K; Timms, P; Allan, JA; Huston, WM |
| 2022 | Activation of the AIM2 Receptor in Circulating Cells of Post-COVID-19 Patients With Signs of Lung Fibrosis Is Associated With the Release of IL-1α, IFN-α and TGF-β. | Colarusso, C; Terlizzi, M; Maglio, A; Molino, A; Candia, C; Vitale, C; Hansbro, PM; Vatrella, A; Pinto, A; Sorrentino, R |
| 2017-04-13 | Graphene quantum dot based "switch-on" nanosensors for intracellular cytokine monitoring. | Liu, G; Zhang, K; Ma, K; Care, A; Hutchinson, MR; Goldys, EM |
| 2022-11 | Single-cell transcriptomic atlas reveals distinct immunological responses between COVID-19 vaccine and natural SARS-CoV-2 infection. | Wang, Y; Wang, X; Luu, LDW; Li, J; Cui, X; Yao, H; Chen, S; Fu, J; Wang, L; Wang, C; Yuan, R; Cai, Q; Huang, X; Huang, J; Li, Z; Li, S; Zhu, X; Tai, J |
| 2023-02-08 | Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients. | Rouet, R; Henry, JY; Johansen, MD; Sobti, M; Balachandran, H; Langley, DB; Walker, GJ; Lenthall, H; Jackson, J; Ubiparipovic, S; Mazigi, O; Schofield, P; Burnett, DL; Brown, SHJ; Martinello, M; Hudson, B; Gilroy, N; Post, JJ; Kelleher, A; Jäck, H-M; Goodnow, CC; Turville, SG; Rawlinson, WD; Bull, RA; Stewart, AG; Hansbro, PM; Christ, D |
